SOS/VOD Diagnosis and Grading vs EBMT 2023 Uso & Estadísticas

The SOS/VOD Pedi-AYA mobile app supports clinicians with diagnosis and grading of Sinusoidal obstructive syndrome (SOS), also known as hepatic veno-occlusive disease (VOD), a potentially life- threatening complication following hematopoietic cell transplantation (HCT) or conventional chemotherapy, and radiotherapy not associated with HCT. SOS/VOD Pedi-AYA mobile app is intended for use by healthcare professionals experienced with treating patients with SOS/VOD only! Always seek advice from a physician before making any medical decisions.
  • App Store de Apple
  • Gratis
  • Educación

Clasificación de tiendas

- -

The 49th EBMT Annual Meeting includes the 39th EBMT Nurses Group Meeting, the 22nd Data Management Group Meeting, the 17th Patient, Family and Donor Day, the 15th Quality Management Group Meeting, the 12th Cell Therapy Day, the 12th Paediatrics Day, the 8th Pharmacists Day, the 7th Psychiatry and Psychology Day, the 5th Transplant Coordinators Day, the 4th Multi-stakeholder Forum on Innovative Cellular Therapies, the 4th Lab Technicians Day, the 2nd Trainee Day and 1st Practice Harmonization Day The Scientific Programme of EBMT 2023 will offer a great selection of symposia and educational sessions related to the current challenges of Haematopoietic Stem Cell Transplantation (HSCT) and Cell Therapy
  • App Store de Apple
  • Gratis
  • Educación

Clasificación de tiendas

- -

SOS/VOD Diagnosis and Grading frente a EBMT 2023: comparación de la clasificación

Comparar la tendencia de clasificación de SOS/VOD Diagnosis and Grading en los últimos 28 días con EBMT 2023

Rank

No hay datos disponibles

Comparación de las clasificaciones SOS/VOD Diagnosis and Grading frente a EBMT 2023 por países

Comparar la tendencia de clasificación de SOS/VOD Diagnosis and Grading en los últimos 28 días con EBMT 2023

No hay datos para mostrar

Compara con cualquier sitio gracias a nuestra prueba gratuita

Empieza ya
SOS/VOD Diagnosis and Grading VS.
EBMT 2023

enero 18, 2025